InsidersTradesSigma
Track the 科拓生物 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 科拓生物 has recorded 6 public disclosures. Market capitalisation: €3.4bn. The latest transaction was reported on 11 December 2025 (Sale). Among the most active insiders: 乔向前. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,501 of 29,062 companies
52.1
score / 100
Value29
Quality75
FCF yld-5.0%
Earn yld2.8%
EV/EBITDA25.0x
ROE4.9%
Gross mgn52%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 December 2025
Declarations6 total
6 of 6 declarations
About 科拓生物
科拓生物 is a company specializing in the health and pharmaceutical sector, focused on developing biopharmaceutical solutions. It is listed on the XSHE market.